Paul Jaehoon Shim, Jessica Leigh Quintos, Khushnood Faraz, Isabelle Taylor Smith, Amy Jiayue Petty, Matthew Bottomley, Lee Emerson Wheless, Melodi Javid Whitley
Acitretin, commonly used for severe psoriasis and keratinocyte carcinoma chemoprevention in high-risk patients, is contraindicated in patients with end stage renal disease on hemodialysis. However, these patients often lack medication choices and in certain clinical scenarios, the benefits of acitretin may outweigh the potential risks. We identified 24 end stage renal disease patients on HD taking acitretin from Duke and Vanderbilt University Medical Centers. While adverse effects were common, patients did not frequently discontinue the medication due to them...
April 15, 2024: Clinical and Experimental Dermatology